1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
SBIR and STTR Omnibus Grant Solicitations (Parent Announcements) is a grant from the National Institutes of Health (NIH) that funds small businesses engaged in early-stage biomedical research and technology development with commercial potential.
The program supports Phase I feasibility studies and Phase II research and development projects across NIH's priority areas, including mental health, HIV, digital health innovations, and BRAIN Initiative technologies. SBIR awards are for small businesses only, while STTR requires a formal partnership with a U.S. research institution.
Eligible applicants must meet SBA small business size standards and relevant NIH eligibility requirements. Phase I awards are normally up to ,766 and Phase II up to ,838,436. The current application deadline is September 5, 2026.
Get alerted about grants like this
Save a search for “National Institutes of Health (NIH)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
SBIR & STTR Funding Opportunity Announcements - National Institute of Mental Health (NIMH) Due to current HHS and NIH restructuring, some content on nimh. nih. gov is not being updated regularly.
Please refer to clinicaltrials. gov and nih. gov for up-to-date information on NIH research.
Opportunities & Announcements Funding Strategy for Grants Grant Writing & Approval Process SBIR & STTR Funding Opportunity Announcements Please contact program staff to discuss potential applications, prior to submission.
NIH SBIR & STTR Omnibus Funding Announcements PHS 2023 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications PA-24-245 (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-24-246 (Parent SBIR [R43/R44] Clinical Trial Required) PHS 2023 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications PA-24-247 (Parent STTR [R41/R42] Clinical Trial Not Allowed) PA-24-248 (Parent STTR [R41/R42] Clinical Trial Required) Topic Specific SBIR & STTR Funding Opportunity Announcements Innovative Technologies to develop novel tools to prevent and treat HIV in underserved populations NIH and CDC SBIR Contract Solicitation Topic 001 Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays Topic 002 Development of novel In-vitro and In-vivo Models to support NeuroHIV Research SBIR/STTR Commercialization Readiness Pilot (CRP) Program PAR-23-219: Technical Assistance and Late Stage Development (Clinical Trial Not Allowed) PAR-23-220: Technical Assistance and Late Stage Development (Clinical Trial Required) SBIR/STTR High-Priority Areas for Digital Mental Health Innovations SBIR/STTR Program Priorities to Bridge Gaps in Advancing the NIMH Mission Translation of BRAIN Initiative Technologies to the Marketplace NOT-MH-24-115 (SBIR/ STTR Clinical Trial Not Allowed) Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) Note this RFA has a non-standard application due date
Based on current listing details, eligibility includes: Small businesses engaging in early-stage biomedical research and development. Must meet SBA size standards and other eligibility requirements. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Normally up to $275,766 for Phase I and $1,838,436 for Phase II (duration of award); additional funding may be available for SBA Approved Waiver Topics. Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is September 5, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) is sponsored by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). This funding opportunity is a companion to the R21 mechanism and also aims to stimulate research to understand the link between social disconnection and suicidal thoughts and behaviors in late life. It focuses on identifying mechanisms by which social disconnection confers risk for, and social integration protects against, suicidal thoughts and behaviors in late life. This R01 mechanism is appropriate for applications with preliminary data.
PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This omnibus solicitation invites Small Business Innovation Research (SBIR) grant applications from small business concerns for projects that require a clinical trial. Several NIH institutes, including NIDA, NIMHD, and NIMH, participate in this solicitation and have specific interests in health equity, social determinants of health, and behavioral change related to their missions.